From the Journals

Rethinking the Biology of Chronic Myeloid Leukemia

New research from UC Irvine challenges a long-standing assumption in chronic myeloid leukemia

  • February 11, 2026

Share

Related Content

New Collaboration to Automate Cell Therapy Manufacturing with Robotics

Focus on scaling cell therapy manufacturing using GMP-ready end-to-end robotic biomanufacturing technology

  • February 12, 2026

  • 2 min
Refining Conditioning Intensity for Older Adults Undergoing Transplant

New data presented at ASH 2025 highlight how age, physiologic reserve and toxicity risk should guide conditioning intensity in older patients undergoing transplant.

  • February 11, 2026

New data, recurring questions

Where do noncovalent BTK inhibitors fit in chronic lymphocytic leukemia (CLL) care?

  • February 11, 2026